Polar Capital Holdings Plc - Q2 2023 holdings

$19.8 Billion is the total value of Polar Capital Holdings Plc's 286 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
 ATLASSIAN CORPORATIONcall$1,720,320,996
-2.0%
10,251,6000.0%8.68%
-23.9%
VRTX  VERTEX PHARMACEUTICALS INC$131,966,250
+11.7%
375,0000.0%0.67%
-13.2%
RVNC  REVANCE THERAPEUTICS INC$105,488,081
-21.4%
4,167,8420.0%0.53%
-39.0%
RE  EVEREST RE GROUP LTD$95,720,800
-4.5%
280,0000.0%0.48%
-25.8%
REGN  REGENERON PHARMACEUTICALS$95,206,550
-12.6%
132,5000.0%0.48%
-32.1%
ALKS  ALKERMES PLC$90,394,901
+11.0%
2,888,0160.0%0.46%
-13.8%
EXEL  EXELIXIS INC$63,462,361
-1.5%
3,320,8980.0%0.32%
-23.6%
 RYAN SPECIALTY HOLDINGS INCcl a$59,479,250
+11.6%
1,325,0000.0%0.30%
-13.3%
FAF  FIRST AMERN FINL CORP$54,169,000
+2.4%
950,0000.0%0.27%
-20.4%
SNY  SANOFIsponsored adr$53,900,000
-1.0%
1,000,0000.0%0.27%
-22.9%
 HAGERTY INC$42,884,759
+7.1%
4,581,7050.0%0.22%
-16.9%
APLS  APELLIS PHARMACEUTICALS INC$42,361,500
+38.1%
465,0000.0%0.21%
+7.5%
MMSI  MERIT MED SYS INC$40,894,022
+13.1%
488,9290.0%0.21%
-12.3%
BMRN  BIOMARIN PHARMACEUTICAL INC$36,839,000
-10.9%
425,0000.0%0.19%
-30.6%
AFL  AFLAC INC$36,296,000
+8.2%
520,0000.0%0.18%
-16.1%
INSM  INSMED INC$35,687,464
+23.8%
1,691,3490.0%0.18%
-3.7%
RLI  RLI CORP$35,482,200
+2.7%
260,0000.0%0.18%
-20.1%
ADUS  ADDUS HOMECARE CORP$35,217,935
-13.2%
379,9130.0%0.18%
-32.3%
PRA  PROASSURANCE CORP$32,632,125
-18.3%
2,162,5000.0%0.16%
-36.5%
 NUTANIX INCnote 0.250%10/0$30,631,006
+1.5%
36,010,0000.0%0.16%
-20.9%
ITCI  INTRA-CELLULAR THERAPIES INC$25,328,000
+16.9%
400,0000.0%0.13%
-9.2%
DCPH  DECIPHERA PHARMACEUTICALS IN$24,640,000
-8.9%
1,750,0000.0%0.12%
-29.5%
MRUS  MERUS N V$19,747,500
+43.1%
750,0000.0%0.10%
+11.1%
 BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$16,938,010
-4.3%
17,200,0000.0%0.08%
-26.1%
BKR  BAKER HUGHES COMPANYcl a$10,641,759
+9.5%
336,6580.0%0.05%
-14.3%
SYK  STRYKER CORPORATION$9,622,234
+6.9%
31,5390.0%0.05%
-15.5%
ROK  ROCKWELL AUTOMATION INC$8,433,261
+12.3%
25,5980.0%0.04%
-12.2%
WMT  WALMART INC$8,243,148
+6.6%
52,4440.0%0.04%
-16.0%
MU  MICRON TECHNOLOGY INC$6,851,095
+4.6%
108,5580.0%0.04%
-18.6%
 BENTLEY SYS INCnote 0.375% 7/0$6,810,000
+6.9%
7,500,0000.0%0.03%
-17.1%
 SPLUNK INCnote 1.125% 9/1$6,516,250
+3.3%
6,500,0000.0%0.03%
-19.5%
AMGN  AMGEN INC$5,193,492
-8.2%
23,3920.0%0.03%
-29.7%
EMR  EMERSON ELEC CO$4,702,721
+3.7%
52,0270.0%0.02%
-17.2%
 MOBILEYE GLOBAL INC$4,556,304
-11.2%
118,5920.0%0.02%
-30.3%
 MACOM TECH SOLUTIONS HLDGS Inote 0.250% 3/1$4,060,000
-3.9%
4,000,0000.0%0.02%
-25.9%
 PATRICK INDS INCnote 1.750%12/0$2,928,000
+7.5%
3,000,0000.0%0.02%
-16.7%
 ENCORE CAP EUROPE FIN LTDnote 4.500% 9/0$2,503,125
-6.0%
2,250,0000.0%0.01%
-23.5%
 MIDDLEBY CORPnote 1.000% 9/0$2,181,375
+0.1%
1,750,0000.0%0.01%
-21.4%
 ASPEN TECHNOLOGY INC$2,058,586
-26.8%
12,2820.0%0.01%
-44.4%
 SNAP INCnote 0.750% 8/0$1,759,875
+0.7%
1,900,0000.0%0.01%
-18.2%
EVH  EVOLENT HEALTH INCcl a$1,414,192
-6.6%
46,6730.0%0.01%
-30.0%
FTCH  FARFETCH LTDord sh cl a$697,940
+23.0%
115,5530.0%0.00%0.0%
ATRC  ATRICURE INC$760,884
+19.1%
15,4150.0%0.00%0.0%
 QUIDELORTHO CORP$859,673
-7.0%
10,3750.0%0.00%
-33.3%
APTV  APTIV PLC$510,450
-9.0%
5,0000.0%0.00%
-25.0%
 LI AUTO INCnote 0.250% 5/0$684,000
+22.8%
500,0000.0%0.00%
-25.0%
BRKR  BRUKER CORP$441,672
-6.2%
5,9750.0%0.00%
-33.3%
TNDM  TANDEM DIABETES CARE INC$275,093
-39.6%
11,2100.0%0.00%
-66.7%
FLDM  STANDARD BIOTOOLS INC$193,000
-1.0%
100,0000.0%0.00%0.0%
OMCL  OMNICELL COM$262,855
+25.6%
3,5680.0%0.00%0.0%
STXS  STEREOTAXIS INC$117,331
-25.0%
76,6870.0%0.00%0.0%
CSTL  CASTLE BIOSCIENCES INC$183,821
-39.6%
13,3980.0%0.00%
-50.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2023-12-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP12Q3 20235.8%
APPLE INC12Q3 20234.7%
ALPHABET INC12Q3 20233.3%
NVIDIA CORPORATION12Q3 20235.4%
ALPHABET INC12Q3 20233.0%
ADVANCED MICRO DEVICES INC12Q3 20232.7%
META PLATFORMS INC12Q3 20233.3%
ARCH CAP GROUP LTD12Q3 20232.5%
AMAZON COM INC12Q3 20232.3%
CHUBB LIMITED12Q3 20231.9%

View Polar Capital Holdings Plc's complete holdings history.

Latest significant ownerships (13-D/G)
Polar Capital Holdings Plc Q2 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aeglea BioTherapeutics, Inc.July 28, 20233,936,1985.0%
INFINITY PHARMACEUTICALS, INC.February 14, 20232,071,2422.3%
Quotient LtdSold outFebruary 14, 202300.0%
Summit Therapeutics Inc.Sold outFebruary 14, 202300.0%
BELLUS Health Inc.February 14, 20222,500,0002.4%
Oxford Immunotec Global PLCSold outFebruary 14, 202200.0%

View Polar Capital Holdings Plc's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
SC 13G2024-02-13
13F-HR/A2023-12-13
13F-HR/A2023-12-13

View Polar Capital Holdings Plc's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Polar Capital Holdings Plc's holdings